NKY Medical Holdings (SZSE:300109) Operating Cash Flow per Share : ¥1.59 (TTM As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Operating Cash Flow per Share?

NKY Medical Holdings's operating cash flow per share for the three months ended in Mar. 2024 was ¥0.41. NKY Medical Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.59.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of NKY Medical Holdings was 2.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 21.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 34.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for NKY Medical Holdings's Operating Cash Flow per Share or its related term are showing as below:

SZSE:300109' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -34.1 Med: 21.6 Max: 125.1
Current: 21.6

During the past 13 years, NKY Medical Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 125.10% per year. The lowest was -34.10% per year. And the median was 21.60% per year.

SZSE:300109's 3-Year OCF Growth Rate is ranked better than
69.24% of 803 companies
in the Drug Manufacturers industry
Industry Median: 7 vs SZSE:300109: 21.60

NKY Medical Holdings Operating Cash Flow per Share Historical Data

The historical data trend for NKY Medical Holdings's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Operating Cash Flow per Share Chart

NKY Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.29

0.84

0.13

0.73

1.51

NKY Medical Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.32	0.23	0.52	0.44	0.41

Competitive Comparison of NKY Medical Holdings's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, NKY Medical Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NKY Medical Holdings's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NKY Medical Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NKY Medical Holdings's Price-to-Operating-Cash-Flow falls into.

NKY Medical Holdings Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

NKY Medical Holdings's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	488.252	/	324.360
	=	1.51

NKY Medical Holdings's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	129.324	/	319.441
	=	0.40

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.59

NKY Medical Holdings Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

NKY Medical Holdings (SZSE:300109) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450

Website

http://www.boai-nky.com

NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.

Executives

Zhang Jun Zheng	Directors, executives
Yang Hong Bo	Director
Wang Dong Hu	Director
Ren Da Long	Director
Xing Xiao Liang	Directors, executives
Zou Xiao Wen	Executives
Wang Shi Gang	Executives
Wang Xin Meng	Executives
Qu Yun Xia	Supervisors
Wang Jian Qiang	Director
Yang Hai Jiang	Director
Yan Zhong Chao	Supervisors
Liu Ai Min	Executives
Wu Cong Zhou	Executives
Wu Wen Bin	Director

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines